No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Botanix Pharmaceuticals Ltd: Appendix 4D and Half Year Report
Botanix Pharmaceuticals' Prescription Gel Commercial Launch Could Drive Stock Re-rating, Euroz Hartleys Says
5 ASX All Ords Shares Starting the New Year at 52-week Highs
Those Who Invested in Botanix Pharmaceuticals (ASX:BOT) Three Years Ago Are up 443%
Botanix Pharmaceuticals Says US Payer Group to Cover Its Excessive Sweat Medication; Shares Up 6%
Botanix Pharmaceuticals on Track to Launch Patient Experience Program for Sofdra in Q4; Shares Up 6%